IVF Clinic Success Rates in 2026: How a 28-Point SART Gap and Rising Loan Rates Should Decide Where You Cycle Next

You just got two quotes. Clinic A wants $14,800 per cycle. Clinic B wants $19,200. Your gut says go with Clinic A — same protocol, same meds list, $4,400 cheaper. But nobody handed you the number that actually determines whether you take home a baby: the live birth rate, broken down for someone your age with your diagnosis, at each of those two specific clinics.

That number can vary by 20 to 30 percentage points between clinics in the same metro area. A $4,400 discount doesn't mean much if it comes attached to a success rate that's half as good — because "half as good" usually means paying for two cycles instead of one, which erases the discount and then some. This is the comparison most patients never get to make, because SART's public reporting tool wasn't built for patients — it was built for regulators. Let's fix that.

What SART Data Actually Tells You (and What It Hides)

The Society for Assisted Reproductive Technology (SART) requires every U.S. fertility clinic to report outcomes annually. The headline number most people look at — "live birth rate per intended retrieval" — sounds simple. It isn't, for three reasons:

• Age bands are wide. A clinic's "35-37" bucket blends a 35-year-old with excellent ovarian reserve and a 37-year-old with diminished reserve. Their real odds could differ by 15 points, but they show up as one average.
• Cancellation rates aren't in the headline number. A clinic that cancels 18% of cycles before retrieval (because the patient didn't respond well to stimulation) looks like it's protecting patients from a doomed cycle — but it also means the clinic never has to report that patient's poor outcome. A lower cancellation rate can actually signal a more aggressive, more transparent clinic.
• "Intended retrieval" vs. "per transfer" tell different stories. Per-transfer rates look better because they exclude everyone who never made it to an embryo. If you're comparing clinics, per-intended-retrieval is the honest number.

We broke down exactly how to read these bands for your specific age in IVF Live Birth Rates at 35, 38, and 41: How to Read SART Clinic Data Before Committing to a $25K Cycle. The short version: never compare clinics on the number they put on their homepage. Compare them on the SART.org report, filtered to your age band and your diagnosis, using per-intended-retrieval live birth rate.

The Comparison Nobody Hands You

Here's a worked example — illustrative numbers, not a real clinic dataset, but structured exactly the way a SART comparison should look for a 37-year-old with a diminished ovarian reserve diagnosis:

	Clinic A	Clinic B	Clinic C
Quoted cycle cost	$14,800	$19,200	$16,500
SART live birth rate (age 35-37, per intended retrieval)	24%	41%	33%
Cancellation rate	22%	9%	14%
Avg. embryos to PGT-A	2.1	3.8	3.0

Clinic A's lower price and higher cancellation rate together suggest it may be triaging harder patients out before they ever count against its numbers — or it may just run a more conservative stimulation protocol. Either way, a 24% live birth rate means the expected number of cycles to reach a live birth is roughly 1 ÷ 0.24 ≈ 4.2, versus 1 ÷ 0.41 ≈ 2.4 at Clinic B. Multiply those out against the quoted price and the "cheaper" clinic could cost more per live birth, not less. This is the kind of analysis Feralyx runs for you — so you don't have to build the spreadsheet yourself.

Is the Clinic Actually Better, or Just Picking Easier Patients?

This is the question every patient should ask before trusting a glossy success-rate claim. A clinic operating in a market with more competition tends to accept a broader range of patients (including harder cases) because it has to fill its calendar. A clinic with a local monopoly — often in a smaller or rural market — can be more selective, decline harder cases, and post a rate that looks great without being better at treating your specific situation.

That selection effect matters more right now because of where fertility care is expanding. States have been pouring rural health dollars into unproven tech ventures, betting that startups can plug gaps left by vanished OB-GYNs and shuttered hospital maternity wards — Louisiana alone drew more than 200 pitches for a program offering $250,000 to $3 million in seed funding to rural health innovators, according to KFF Health News reporting on the trend. Fertility care is following the same access curve: rural patients increasingly rely on a single regional clinic or a telehealth-plus-satellite-monitoring setup, with limited ability to shop around. If you're one of those patients, you're not really choosing "the best clinic" — you're choosing "the only clinic within driving distance," which makes it even more important to know your SART numbers cold before you commit, and to factor in what you'd need to travel or relocate temporarily for a second opinion. We've written more on how rural access gaps translate into real out-of-pocket exposure in IVF Insurance Coverage in 2026: Why Mandate States, the ERISA Loophole, and Rural Doctor Shortages Leave Patients With a $15K–$35K Out-of-Pocket Gap.

The Medication Line Item You Can't Compare Clinic-to-Clinic

Even once you've picked a clinic based on real SART data, the quote you got is not your total cost. Medications typically add $4,000-$7,000 per cycle on top of the base fee, and that's where a different kind of pricing distortion is showing up. Arkansas pharmacies filed a first-of-its-kind lawsuit against Express Scripts, alleging the pharmacy benefit manager systematically underpaid them relative to the National Average Drug Acquisition Cost (NADAC) benchmark — a dispute that, per Healthcare Dive's coverage, exposes how opaque the pricing chain between manufacturer, PBM, and pharmacy really is for specialty drugs, the same category fertility medications fall into. Two patients on the identical stimulation protocol, filling at two different pharmacies under two different insurance/PBM arrangements, can pay wildly different amounts for the same vials of gonadotropins. That's on top of clinic-to-clinic variation.

This is exactly why comparing quoted cycle price alone is misleading — the real number you need is total out-of-pocket including meds, monitoring, and PGT-A. We go deep on that build-out in IVF Cycle Cost Breakdown: Why Medications, PGT-A, and Monitoring Add $12K–$20K to Any Clinic Quote in 2026. Before you sign with any clinic, ask for their typical total (not just base fee) for someone with your specific protocol — and get your pharmacy benefit checked separately, because the PBM layer is invisible on the clinic's own estimate sheet.

Why the Financing Math Just Got Worse

Here's the part that changes the calculus on choosing a higher-success, higher-cost clinic versus a cheaper one: borrowing got more expensive. The Federal Reserve raised its benchmark rate by a quarter point in September, pushing the federal funds target range to 3.75%-4% — the first hike since 2023, per NerdWallet's coverage of the move. Rate hikes flow through to personal loan APRs and medical credit products with a lag, but they flow through. If you're financing a $19,000 cycle at a clinic with a materially better SART rate versus a $15,000 cycle at a clinic with a materially worse one, the interest you'll pay on the extra $4,000 needs to be weighed against the interest you'd pay financing a second cycle at the cheaper, lower-success clinic if the first one fails. In a rising-rate environment, that second-cycle risk gets more expensive every quarter you wait. Mortgage rates pushing back toward 7% ahead of the Fed's move — as markets priced in the hike, per NerdWallet's mortgage coverage — is a signal of the same broader trend: if you were planning to tap a HELOC to cover fertility costs, that option got pricier too.

We built out the shared-risk-versus-loan-versus-payment-plan break-even math for exactly this kind of decision in IVF Financing After a Failed Cycle: Shared-Risk Program vs. Personal Loan vs. Clinic Payment Plan. The core insight holds even more now: a shared-risk or refund program that guarantees a partial refund after 2-3 failed cycles can be worth its premium precisely because it insulates you from financing a third cycle at 2026 loan rates. You can model this for your specific situation — your quotes, your SART band, your credit profile — at Feralyx.

The Actual Question to Answer Before You Sign Anything

Not "which clinic is cheaper" and not "which clinic has the higher headline success rate." The question is: what is my expected total out-of-pocket cost per live birth, across up to three cycles, at each clinic I'm considering — including meds, PGT-A, monitoring, and financing costs at today's rates?

That's a multi-variable calculation most patients are asked to do in their head while sitting in a consult room, emotionally exhausted, with a nurse waiting for an answer. It shouldn't be done that way. If you have two or three quotes and SART data for the clinics behind them, that's already enough to build a real comparison — you just need somewhere to run the numbers against your age, diagnosis, insurance situation, and how many cycles you're financially and emotionally prepared to do. That's what Feralyx is built for: put in your own numbers, see the full cost-and-probability picture across clinics, and make the next decision with data instead of a gut feeling and a spreadsheet you built at midnight.

Sources

• States Bet Big on Rural Health Startups, With a Silicon Valley Twist — KFF Reproductive Health
• Express Scripts targeted by Arkansas pharmacies in first-of-its-kind lawsuit — Healthcare Dive
• Fed Hikes Rate for the First Time Since 2023 — NerdWallet Health
• New AmEx Centurion Lounge in Amsterdam Only for Flyers Departing Schengen — NerdWallet Health
• Why Mortgage Rates Shot Toward 7% Before the Fed Raised Rates — NerdWallet Health